Saudi Arabia Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The saudi arabia ophthalmic devices market size is expected to grow from USD 580 million in 2025 to USD 611.21 million in 2026 and is forecast to reach USD 794.18 million by 2031 at 5.38% CAGR over 2026-2031. This report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, and Other Disease Indication), End User (Hospitals, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Saudi Arabia Ophthalmic Devices Market Trends and Insights

Government-Funded Vision 2030 Ophthalmology Infrastructure Expansion

Vision 2030 seeks to raise private-sector participation in healthcare to 68% by 2030 and add about 84,000 beds to reach OECD standards. Expansion plans by large hospital groups - such as Dr Sulaiman Al Habib Medical Services, which intends to grow capacity from 1,913 to 3,609 beds by 2028 - translate directly into higher purchases of surgical microscopes, optical-coherence-tomography (OCT) scanners, and tele-ophthalmology platforms. The SEHA Virtual Hospital now links more than 150 hospitals, enabling remote retinal assessments and extending specialist reach.

High Diabetes Prevalence Driving AI-Based Diabetic-Retinopathy Screening Uptake

Diabetes affects 31.0% of adults in the Kingdom, and diabetic retinopathy (DR) impacts 46% of diabetics in the Western region. An AI-enabled national tele-retinopathy programme launched in 2024 accelerates screening throughput and accuracy. Early results indicate a 30.0% reduction in unnecessary referrals, spurring demand for AI-ready fundus cameras and cloud-integrated image-management systems. Persistent knowledge gaps - 29% of patients report never having had an eye exam - are addressed by payer-funded awareness drives that should boost device utilisation.

Import Dependence Inflating Device Prices

The SFDA mandates ISO 13485 certification and local Authorised Representatives, raising import-transaction costs. Beginning January 2025, all medical devices also require SABER platform conformity certificates, which add compliance fees that sellers pass through to buyers. These expenses elevate landed costs - particularly for premium imaging equipment - by an estimated 15%, dampening uptake in smaller clinics.

Other drivers and restraints analyzed in the detailed report include:

• Compulsory Premarital & School Eye-Health Screening Programmes
• Rise of Premium Elective LASIK & Cataract Surgeries Via Medical-Tourism Hubs
• Shortage of Certified Ophthalmic Technicians Limiting Diagnostic Throughput

Segment Analysis

Vision care devices retained a 59.83% share of the Saudi Arabia ophthalmic devices market in 2025, supported by steady demand for spectacles, contact lenses, and dispensing systems. Diagnostic & Monitoring Devices, however, are set to expand at a 7.42% CAGR through 2031, reflecting hospitals’ shift toward early-stage disease identification. Within this cluster, optical-coherence-tomography scanners should command 24.18% of diagnostic revenue in 2025, benefiting from superior retinal-layer visualisation that aids macular-degeneration and diabetic-retinopathy screening. Ultra-wide-field fundus cameras also post strong orders because clinicians want comprehensive peripheral-retina images to detect lesions missed by 45-degree systems.

The diagnostic up-cycle is reinforced by national tele-health mandates that integrate cloud-based image management and AI grading. As a result, the Saudi Arabia ophthalmic devices market size allocated to diagnostic hardware rises in tandem with digitally linked screening programmes. Surgical-device demand grows at a moderate clip, buoyed by premium intra-ocular-lens adoption in elective cataract and refractive procedures popular in Riyadh and Jeddah. Import tariffs remain a drag on smaller buyers, but multinational suppliers offset duties with leasing options and bundled-service contracts.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • OCT Scanners
    • Fundus & Retinal Cameras
    • Autorefractors & Keratometers
    • Corneal Topography Systems
    • Ultrasound Imaging Systems
    • Perimeters & Tonometers
    • Other Diagnostic & Monitoring Devices
  • Surgical Devices
    • Cataract Surgical Devices
    • Vitreoretinal Surgical Devices
    • Refreactive Surgical Devices
    • Glaucoma Surgical Devices
    • Other Surgical Devices
  • Vision Care Devices
    • Spectacles Frames & Lenses
    • Contact Lenses
• By Disease Indication
  • Cataract
  • Glaucoma
  • Diabetic Retinopathy
  • Other Disease Indications
• By End-user
  • Hospitals
  • Specialty Ophthalmic Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End-users

List of Companies Covered in this Report:

• Alcon
• Bausch Health
• Carl Zeiss
• Johnson & Johnson Vision Care
• EssilorLuxottica
• NIDEK Co Ltd
• Topcon Corp
• HAAG-Streit
• Glaukos Corp
• CooperVision Inc
• STAAR Surgical
• Lumibird Medical
• Oculus Optikgerte GmbH
• Reichert Technologies
• BVI Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support